New INCA Membership Committee Chair
Dirk Van Genechten, Vice President of vzw NET & MEN Kanker Belgium, is the new INCA Membership Committee Chair. He stepped up to this role after a long-standing and highly-valued contribution as a member of this committee. Dirk has also provided a committed...
Patient Leaders and NET Experts Speak in One Voice at the INCA/ENETS Symposium on March 23rd
This year, the INCA/ENETS Symposium will take place within the 20th Annual ENETS Conference on March 23rd, 2023 from 11:00 am – 12:00 pm CET, in Vienna, Austria, and online. The program will showcase the impact of collaborative efforts for improvement of patient...
Cancer Patients Have the Right to Informed and Shared Decision-Making Along the Entire Patient Pathway
A Virtual Meeting on Informed and Shared Decision-Making, between cancer patients, caregivers and healthcare professionals, was held on January 18th, 2023, organized by the European Cancer Organisation (ECO) in collaboration with the Anticancer Fund and connected to...
NET Research Foundation Is Now Offering NETWise Podcasts in Spanish
A special new NETWise project by the NET Research Foundation (NETRF) is now launched. The pilot episode of the NETWise series translated into Spanish is already available on NETRF website. This very first podcast of the series lays out the most basic and foundational...
UK Clinical ‘Trials That Matter’ Overview by Neuroendocrine Cancer UK
A valuable overview of the most important clinical trials for UK neuroendocrine cancer patients was made by Kate Quirk from Neuroendocrine Cancer UK. The article on NCUK website includes basic educational background for patients on clinical trials and also highlights...
2022 Discoveries in the NET field: Summary by NET Еxperts and LACNETS
LACNETS published the video of the webinar with medical oncologist Dr. Thorvardur Halfdanarson of Mayo Clinic – "2022: Year in Review". Dr. Halfdanarson’s presentation summarizes in a very accessible way the key discoveries in the NET field in 2022 and what research...
NECA Participated in the CommNETS Annual Research Workshop
NeuroEndocrine Cancer Australia (NECA) attended the annual CommNETs (Commonwealth countries – Canada, Australia and New Zealand) Research Workshop held from 30 November to 2 December 2022 in Hawaii. Many clinical trials were discussed with expressions of interest made...
Victory NET Foundation’s New Partner in Switzerland
The Victory NET Foundation is pleased to introduce its new partner in Switzerland: CHUV Center of Excellence for neuroendocrine tumors in Lausanne. Driven by the extraordinary work of Professor Niklaus Schaefer and his specialized nurse Geneviève Sirena, this Center...
INCA’s 2022 Review With Impactful Events and Resources
INCA wrapped up an exciting 2022, full of impactful events, new member organizations, new information resources and the most successful NET Cancer Day campaign to date. Novel projects to raise neuroendocrine cancer awareness among healthcare professionals and...
Neuroendocrine Cancer Patient Testimonial from Germany on Radioligand Therapy Experience
INCA has collaborated with SPARC-Europe on release of five neuroendocrine cancer patients testimonials on experience with radioligand therapy (RLT). The videos feature patient stories from Italy, Bulgaria, France, Germany and Sweden. Throughout their stories,...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
